Unique ID issued by UMIN | UMIN000036705 |
---|---|
Receipt number | R000041801 |
Scientific Title | An observational study focusing on the changes of the upper eyelid sulcus after switching from FP receptor agonist to EP2 receptor agonist |
Date of disclosure of the study information | 2019/05/10 |
Last modified on | 2023/04/20 16:15:55 |
An observational study focusing on the changes of the upper eyelid sulcus after switching from FP receptor agonist to omidenepag isoproryl ophthalmic solution
An observational study focusing on the changes the upper eyelid sulcus after switching to omidenepag isoproryl ophthalmic solution
An observational study focusing on the changes of the upper eyelid sulcus after switching from FP receptor agonist to EP2 receptor agonist
An observational study focusing on the changes the upper eyelid sulcus after switching to EP2 receptor agonist
Japan |
Glaucoma, ocular hypertension
Ophthalmology |
Others
NO
To evaluate the changes of the upper eyelid sulcus and to assess the QOL after switching from FP receptor agonist to omidenepag isopropyl ophthalmic solution 0.002% for glaucoma or ocular hypertension patients
Safety,Efficacy
Exploratory
Not applicable
Changes of findings and subjective symptom and quality of life about the upper eyelid sulcus
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) a patient with glaucoma or ocular hypertension
2) a patient treats FP receptor agonist for glaucoma or ocular hypertension
3) a patient who has a desire to change their eyedrops because of impaired quality of life due to the deepening of the upper eyelid sulcus after topical use of FP receptor agonist. And that is the case where it seems to be appropriate to switch from FP receptor agonist to omidenepag isopropyl ophthalmic solution 0.002% by the research group
4) an outpatient
1) a patient with aphakic or pseudophakic eyes
2) a patient with hypersensitivity to Omidenepag isopropyl ophthalmic solution 0.002%
30
1st name | Makoto |
Middle name | |
Last name | Aihara |
Yotsuya Shirato Eye Clinic
Ophthalmology
160-0004
Yotsuya Mitsuke building 3F, 1-1-2, Yotsuya, Shinjyuku-ku, Tokyo
03-3355-4281
aihara-tky@umin.net
1st name | Rei |
Middle name | |
Last name | Sakata |
Yotsuya Shirato Eye Clinic
Ophthalmology
160-0004
Yotsuya Mitsuke building 3F, 1-1-2, Yotsuya, Shinjyuku-ku, Tokyo
03-3355-4281
reisakata-tky@umin.ac.jp
Yotsuya Shirato Eye Clinic
Santen Pharmaceutical Co., Ltd.
Profit organization
Medical Corporation TOUKEIKAI Kitamachi Clinic ERB
1-3, Kichijoji Kitamachi, Musashino-shi, Tokyo
070-5011-8550
shingo-namiki@j-smo.com
NO
2019 | Year | 05 | Month | 10 | Day |
https://pubmed.ncbi.nlm.nih.gov/36318495/
Published
https://pubmed.ncbi.nlm.nih.gov/36318495/
23
https://pubmed.ncbi.nlm.nih.gov/36318495/
2023 | Year | 04 | Month | 20 | Day |
Refer to paper
Refer to paper
Refer to paper
Refer to paper
Completed
2019 | Year | 04 | Month | 02 | Day |
2019 | Year | 04 | Month | 16 | Day |
2019 | Year | 05 | Month | 31 | Day |
2021 | Year | 01 | Month | 25 | Day |
To evaluate the changes of the upper eyelid sulcus and to assess the QOL after switching from FP receptor agonist to omidenepag isopropyl ophthalmic solution 0.002% for glaucoma or ocular hypertension patients
2019 | Year | 05 | Month | 10 | Day |
2023 | Year | 04 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041801
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |